Decision Support Intervention of Minor Cancer Patients and Their Parents

NCT ID: NCT06651242

Last Updated: 2025-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-26

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this stuidy are: (1) to explore the information needs of parents having children with cancer when making treatment decisions; (2) to develop a Taiwan version of the Control Preferences Scale for decision support aids; (3) to implement and evaluate the effectiveness of involving minor cancer patients and their parents in treatment decision-making.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Cancer Adolescent Health Decision Aids Parents of Children With Cancer Decision Making ,Shared

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Decision-making information aids

Group Type EXPERIMENTAL

Decision-making information aids

Intervention Type OTHER

Provide a decision-making information aids to assist patients and their parents in treatment decision making.

Routine care

Group Type SHAM_COMPARATOR

Routine care

Intervention Type OTHER

Routine care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Decision-making information aids

Provide a decision-making information aids to assist patients and their parents in treatment decision making.

Intervention Type OTHER

Routine care

Routine care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age over 20 years.
2. Child under 20 years old, diagnosed with cancer by a doctor.
3. their child know her/his cancer diagnosis.
4. Agree to have the child participate in family meeting and have ability to communicate in Mandarin or Taiwanese.

1. Aged between 7 and 20 years, diagnosed with pediatrtic cancer.
2. Aware of their cancer diagnosis.
3. Able to express their thoughts to the researcher in Mandarin or Taiwanese.
4. Both the minor and their legal guardian consent to participate in the study.

Exclusion Criteria

1. Diagnosed with depression, and/or anxiety, and/or other mental disorders.
2. Legal guardian is unwilling to inform the minor of their diagnosis.
3. Minor is unwilling to share their thoughts with their parents.
Minimum Eligible Age

7 Years

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaohsiung Medical University

Kaohsiung City, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Li-Min Wu, PhD

Role: CONTACT

(886)73121101 ext. 2814

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Li-Min Wu, PhD

Role: primary

(886)73121101 ext. 2814

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KMUHIRB- SV(II)-20220022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.